title: Routine bone scan and serum alkaline phosphatase for staging in patients with renal cell carcinoma is not cost-effective.
authors.forename: S D
authors.initials: SD
authors.lastname: Bos
authors.forename: D A
authors.initials: DA
authors.lastname: Piers
authors.forename: H J
authors.initials: HJ
authors.lastname: Mensink
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000469:Alkaline Phosphatase / Q000097:blood; D001842:Bone and Bones / Q000000981:diagnostic imaging; D002292:Carcinoma, Renal Cell / Q000473:pathology*; D002648:Child; D002675:Child, Preschool; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007680:Kidney Neoplasms / Q000473:pathology*; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging / Q000191:economics*; D011877:Radionuclide Imaging; D013669:Technetium Tc 99m Medronate
chemical_list: C023568:technetium Tc 99m (Sn)methylenediphosphonate; D000469:Alkaline Phosphatase; D013669:Technetium Tc 99m Medronate